Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2

Receptor recognition and subsequent membrane fusion are essential for the establishment of successful infection by SARS-CoV-2. Halting these steps can cure COVID-19. Here we have identified and characterized a potent human monoclonal antibody, HB27, that blocks SARS-CoV-2 attachment to its cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ling, Deng, Yong-Qiang, Zhang, Rong-Rong, Cui, Zhen, Sun, Chun-Yun, Fan, Chang-Fa, Xing, Xiaorui, Huang, Weijin, Chen, Qi, Zhang, Na-Na, Ye, Qing, Cao, Tian-Shu, Wang, Nan, Wang, Lei, Cao, Lei, Wang, Huiyu, Kong, Desheng, Ma, Juan, Luo, Chunxia, Zhang, Yanjing, Nie, Jianhui, Sun, Yao, Lv, Zhe, Shaw, Neil, Li, Qianqian, Li, Xiao-Feng, Hu, Junjie, Xie, Liangzhi, Rao, Zihe, Wang, Youchun, Wang, Xiangxi, Qin, Cheng-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
IMMUNOLOGY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798916/
https://www.ncbi.nlm.nih.gov/pubmed/34676096
http://dx.doi.org/10.1093/nsr/nwaa297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798916/
https://www.ncbi.nlm.nih.gov/pubmed/34676096
http://dx.doi.org/10.1093/nsr/nwaa297

Ejemplares similares